When Will the Sub-$1,000 Human Genome Arrive?
The media swarmed over Illumina's announcement of a system capable of sequencing a human genome for $1,000 in the near future, but when will the company and Thermo Fisher Scientific break that barrier on a routine basis?
The $1,000 Genome Marks the Start of a New Phase in Human Evolution
Unlocking the "human code" makes possible all manner of changes we might have never considered before. Are we ready for what that might mean?
The 3 Most Intriguing Stories From the JPMorgan Healthcare Conference
With roughly 300 companies presenting at the JPMorgan Helathcare Conference, these three stood out above the pack.
Friday's Biggest Health-Care Winner: Illumina, Inc.
Illumina's new machine could be enormous for genome processing, and for investors.
Why Electronic Arts, Illumina, and BlackBerry Jumped Today
Strength in some high-profile Dow stocks masked weakness in the broader market, but that didn't hold back some individual companies from big gains. Electronic Arts jumped 12%, Illumina gained 9%, and BlackBerry ended the day with a 6% rise. Find out more about what made these stocks soar.